Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 38Neoplasms 33Depression 28Fatigue 24Prostatic Neoplasms 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Follicular 17Multiple Myeloma 15Lymphoma, Non-Hodgkin 14Lymphoma, Mantle-Cell 14Leukemia, Lymphocytic, Chronic, B-Cell 14Burkitt Lymphoma 14Lymphoma, B-Cell, Marginal Zone 13Leukemia, Myeloid, Acute 13Hodgkin Disease 13Colorectal Neoplasms 13Lymphoma, Large-Cell, Immunoblastic 12Lung Neoplasms 12Anxiety Disorders 12Lymphoma 11Leukemia, Myeloid, Chronic-Phase 11Blast Crisis 11Leukemia, Myeloid, Accelerated Phase 10Recurrence 9Pain 9Lymphoma, T-Cell, Cutaneous 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Leukemia, Hairy Cell 9Leukemia 9

Interventions

Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Non Small Cell Lung Caner × Therapeutics × Clear all
NCT07110259 2025-08-07

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

The First Affiliated Hospital of Guangzhou Medical University

Phase NA Not yet recruiting
950 enrolled
Thoracic

Non Small Cell Lung Caner

Data powered by HemOnc (CC BY 4.0) Colophon âš¡